Pfizer Inc
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the space’s dominant players Eli Lilly and Novo Nordisk. Those […]
Read More
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro has improved in the U.S. after months of widespread […]
Read More
Moderna stock falls 10% as hefty Covid vaccine write-downs drive big loss
Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product. Moderna’s total revenue for the period topped Wall Street’s expectations, even amid plummeting demand for its shot. Its outlook for next year, however, came in […]
Read More
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion charge for inventory write-offs in the third quarter due […]
Read More
Inventory futures are small altered following important averages rebound to start the 7 days: Live updates
A trader is effective on the floor of the New York Stock Trade on Oct. 20, 2023. Michael Nagle | Bloomberg | Getty Photos U.S. stock futures were being flat Monday night time right after the key averages climbed in a reduction rally. S&P 500 futures and Nasdaq 100 futures just about every inched lower […]
Read More
These stocks have earnings momentum heading into their reports this 7 days
A different chunk of providers are established to report this 7 days, and analysts think earnings are on their aspect. About 50% of S & P 500 corporations have described earnings for the 3rd quarter. Of those businesses, approximately 77% have exceeded expectations, FactSet info exhibits. About 30% of S & P 500 businesses are […]
Read More
CNBC Day-to-day Open up: Are points about to get a lot more difficult?
Up from No. 13 in 2022, Minneapolis, Minnesota ranked as the No. 2 most neighborly city in The usa. S. Greg Panosian | E+ | Getty Photos This report is from today’s CNBC Each day Open, our new, international marketplaces e-newsletter. CNBC Every day Open delivers investors up to velocity on every little thing they […]
Read More
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don’t expect this duopoly to end soon, analysts say. But other companies — both big and small — are hoping to grab a piece of this lucrative market. In a research note, Piper Sandler analyst Yasmeen Rahimi said the firm is tracking more […]
Read More
Jamie Dimon’s stock-moving trades show why investors should track CEOs’ buying and selling
For the first time in nearly two decades running JPMorgan Chase, CEO Jamie Dimon will voluntarily sell stock in the bank. The disclosure, in a securities filing Friday, detailed next year’s planned sales — pressuring JPMorgan (JPM) shares and the Dow Jones Industrial Average and highlighting why tracking trades made by executives involving the companies […]
Read More
Pfizer’s combination Covid, flu vaccine will move to final-stage trial after positive data
CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study. That moves the pharmaceutical giant and its German partner BioNTech one step closer to […]
Read More